Last updated: November 8, 2020
Sponsor: Damascus Hospital
Overall Status: Active - Recruiting
Phase
4
Condition
N/ATreatment
N/AClinical Study ID
NCT04626193
G-10-20
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients are aged greater than 18 years old who have H. pylori infection diagnosed byany of following three methods:
- Positive rapid urease test (CLOtest).
- Histologic evidence of H. pylori by modified Giemsa staining.
- Positive 13C-urea breath test. without prior eradication therapy and are willing toreceive therapy.
Exclusion
Exclusion Criteria:
- Children and teenagers aged less than 18 years.
- Previous eradication treatment for H. pylori.
- Patients who took any drug, which could influence the study results such as protonpump inhibitor, H2 blocker, mucosal protective agent and antibiotics.
- History of gastrectomy.
- Gastric malignancy, including adenocarcinoma and lymphoma,
- Previous allergic reaction to antibiotics (Amoxicillin, Tinadizole,
- Doxycycline,Bismuth subsalicylate,) and prompt pump inhibitors (Es- omeprazole).
- Contraindication to treatment drugs.
- Pregnant or lactating women.
- Severe concurrent disease.
- Liver cirrhosis.
Study Design
Total Participants: 80
Study Start date:
October 31, 2020
Estimated Completion Date:
May 30, 2024
Connect with a study center
General Assembly of Damascus Hospital
Damascus,
Syrian Arab RepublicActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.